TABLE 1

Pharmacokinetic (PK) parameters of MDZ and its metabolites following intravenous administration of MDZ (0.5 mg/kg/h for 4 h) to rhesus monkeys pretreated with vehicle (PEG 400) or rifampin (18 mg/kg p.o.) for 5 days

Values are mean ± S.D., n = 4. Values in parentheses are range.


Compound Measured

PK Parameters

Vehicle Control

Rifampin (18 mg/kg)
% of control
Plasma
    MDZ AUC0-last (μM · h) 3.79 ± 0.39 4.10 ± 0.78 109 ± 13
(97-123)
CL (ml/min/kg) 26.6 ± 3.4 25.2 ± 5.6 94 ± 13
(80-104)
Vdss (l/kg) 1.77 ± 0.50 1.70 ± 0.69 93 ± 18
(67-107)
t1/2 (h) 0.9 ± 0.2 0.8 ± 0.3 90 ± 28
(65-130)
    1′-OH MDZ AUC0-last (μM · h) 0.52 ± 0.32 0.055 ± 0.025* 13 ± 7
(6-23)
    1′-OH MDZ/MDZ Ratio AUC0-last 0.13 ± 0.07 0.013 ± 0.004* 12 ± 6
(5-18)
Urine
    MDZ Recovery (% of dose) 0.03 ± 0.01
    1′-OH MDZ Recovery (% of dose) 1.6 ± 1.3
    1′-OH MDZ glucuronide Recovery (% of dose) 64.8 ± 9.0
    4-OH MDZ (unconjugate + conjugate)
Recovery (% of dose)
0.3 ± 0.1


  • * Statistically significant difference from control (P < 0.05).